Flagship blends three biotech startups to form Etcelera
Etiome, Cellarity and Empress Therapeutics are being combined into one new AI-aided drugmaker claiming to possess the ability to better predict the way new medicines will fare in humans.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.